Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Jul 23, 2020

SELL
$610.05 - $713.9 $183,015 - $214,170
-300 Closed
0 $0
Q1 2020

Apr 23, 2020

SELL
$615.5 - $751.4 $1.11 Million - $1.35 Million
-1,800 Reduced 85.71%
300 $195,000
Q4 2019

Jan 30, 2020

SELL
$688.5 - $846.15 $481,950 - $592,305
-700 Reduced 25.0%
2,100 $1.58 Million
Q1 2019

Apr 09, 2019

SELL
$709.9 - $885.4 $284,669 - $355,045
-401 Reduced 12.53%
2,800 $2.46 Million
Q4 2018

Jan 15, 2019

SELL
$667.94 - $785.7 $403,435 - $474,562
-604 Reduced 15.87%
3,201 $2.37 Million
Q3 2018

Oct 09, 2018

BUY
$602.8 - $699.6 $907,213 - $1.05 Million
1,505 Added 65.43%
3,805 $2.64 Million
Q2 2018

Jul 11, 2018

BUY
$568.25 - $635.8 $1.31 Million - $1.46 Million
2,300 New
2,300 $1.38 Million

Others Institutions Holding ATRI

About ATRION CORP


  • Ticker ATRI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 1,785,990
  • Description
  • Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in vari...
More about ATRI
Track This Portfolio

Track Denali Advisors LLC Portfolio

Follow Denali Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Denali Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Denali Advisors LLC with notifications on news.